What is Xeriant Inc's earnings per share (EPS)?

Xeriant Inc (XERI) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Xeriant Inc Financials

XERI

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE June

This page shows Xeriant Inc (XERI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XERI FY2025 2026-05-15

External financing, not self-funded operations, appears to be the core mechanic as assets shrink and liabilities remain outsized.

Over several fiscal years, share count more than doubled while cash fell from $963K to $45K. That combination implies new financing mainly covered ongoing burn instead of rebuilding the balance sheet, with liabilities still near $5.9M against only $68K of assets.

The last year with both figures reported showed operating loss of -$1.9M and operating cash outflow of -$1.4M running close together, which suggests losses were cash-real rather than mainly accounting-based. With assets down to $68K, the company now looks less like a business funding operations from its own resources and more like one sustained by periodic external capital.

Some figures from recent filings were inconsistent and were omitted from this summary.

Financial Health Signals

Financial Profile 15/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Xeriant Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Xeriant Inc carries a low D/E ratio of -0.00, meaning only $-0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$0.00

YoY+100.0%

Xeriant Inc earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$45K

YoY-93.1%

5Y CAGR+2.9%

10Y CAGR-18.9%

Xeriant Inc held $45K in cash against $3K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

696M

YoY+32.6%

Xeriant Inc had 696M shares outstanding in fiscal year 2025. This represents an increase of 32.6% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$69K

YoY-64.7%

5Y CAGR+61.1%

Xeriant Inc invested $69K in research and development in fiscal year 2025. This represents a decrease of 64.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$2K

10Y CAGR-6.9%

Xeriant Inc invested $2K in capex in fiscal year 2025, funding long-term assets and infrastructure.

XERI Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$69K-64.7%	$196K	$0-100.0%	$5.3M+1311.8%	$373K+5751.8%	$6K
SG&A Expenses	$309K+9.5%	$282K+0.7%	$280K-76.3%	$1.2M+221.7%	$368K+291.8%	$94K
Operating Income	N/A	-$1.9M	N/A	N/A	-$2.2M-506.3%	-$363K
Interest Expense	$226K-80.9%	$1.2M+11104.7%	$11K-92.4%	$139K+1775.3%	$7K-23.8%	$10K
Income Tax	$0	$0	N/A	N/A	$0	$0
Net Income	N/A	-$3.1M	N/A	N/A	-$2.7M-286.3%	-$700K
EPS (Diluted)	$0.00+100.0%	$-0.01	N/A	$-0.05-400.0%	$-0.01	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$30K+81.8%	$16K-69.8%	$54K	N/A	$30K+201393.3%	$15-99.9%	$27K	N/A
SG&A Expenses	$59K+106.9%	$28K+13.9%	$25K	N/A	$102K-29.9%	$146K+158.0%	$56K	N/A
Operating Income	N/A	-$231K+24.0%	-$304K	N/A	N/A	-$336K+6.5%	-$359K	N/A
Interest Expense	$46K+27.3%	$36K-20.0%	$45K	N/A	$66K+28.8%	$51K-16.6%	$62K	N/A
Income Tax	-$24K-51.9%	-$16K-112.8%	$125K	N/A	$0	$0	$0	N/A
Net Income	N/A	-$298K	N/A	N/A	N/A	-$417K-12.1%	-$372K	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

XERI Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$68K-90.4%	$713K+326.6%	$167K-86.8%	$1.3M+10.8%	$1.1M+342.5%	$259K
Current Assets	$57K-91.5%	$664K+904.0%	$66K-93.8%	$1.1M+9.3%	$976K+1749.6%	$53K
Cash & Equivalents	$45K-93.1%	$653K+959.8%	$62K-94.2%	$1.1M+10.7%	$963K+2374.8%	$39K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.9M-8.9%	$6.5M+63.3%	$4.0M-6.4%	$4.2M+861.2%	$440K+51.7%	$290K
Current Liabilities	N/A	N/A	N/A	$4.1M+1284.1%	$299K+181.3%	$106K
Long-Term Debt	$3K	N/A	N/A	N/A	N/A	N/A
Total Equity	-$5.8M-1.2%	-$5.8M-51.7%	-$3.8M-28.1%	-$3.0M-421.2%	$922K+3052.8%	-$31K
Retained Earnings	-$28.3M-6.1%	-$26.7M-13.0%	-$23.6M-42.6%	-$16.6M-406.7%	-$3.3M-317.0%	-$784K

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$44K-57.7%	$103K+44.2%	$72K+5.1%	$68K-6.8%	$73K-73.5%	$277K-22.0%	$355K-50.2%	$713K
Current Assets	$34K-64.4%	$95K+53.9%	$62K+8.8%	$57K-8.5%	$62K-76.9%	$269K-16.0%	$320K-51.8%	$664K
Cash & Equivalents	$25K-67.9%	$77K+46.8%	$52K+16.2%	$45K-16.3%	$54K-78.9%	$254K-15.3%	$300K-54.1%	$653K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.0M+3.4%	$2.9M-1.2%	$2.9M-50.8%	$5.9M+1.8%	$5.8M-5.0%	$6.1M+1.8%	$6.0M-7.4%	$6.5M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$0-100.0%	$508-74.1%	$2K-36.7%	$3K	N/A	N/A	N/A	N/A
Total Equity	-$2.9M-5.7%	-$2.8M+2.3%	-$2.8M+51.5%	-$5.8M-1.9%	-$5.7M+1.7%	-$5.8M-3.3%	-$5.6M+2.1%	-$5.8M
Retained Earnings	-$26.8M-1.6%	-$26.4M-1.1%	-$26.1M+7.9%	-$28.3M-1.2%	-$28.0M-1.9%	-$27.5M-1.5%	-$27.1M-1.4%	-$26.7M

XERI Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$1.4M	N/A	N/A	-$1.0M-189.5%	-$350K
Capital Expenditures	$2K	$0-100.0%	$3K-87.2%	$20K	$0	N/A
Free Cash Flow	N/A	-$1.4M	N/A	N/A	-$1.0M	N/A
Investing Cash Flow	-$2K+78.4%	-$8K+95.9%	-$200K-47.9%	-$135K	$0	N/A
Financing Cash Flow	N/A	$2.0M+448.6%	$370K	N/A	$1.9M+402.2%	$385K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	N/A	-$206K-15.7%	-$178K-3.3%	-$172K+53.0%	-$366K+8.1%	-$398K-12.7%	-$353K+4.7%	-$370K
Capital Expenditures	$3K	N/A	N/A	$2K	N/A	N/A	N/A	$0
Free Cash Flow	N/A	N/A	N/A	-$174K	N/A	N/A	N/A	-$370K
Investing Cash Flow	-$3K	$0	$0+100.0%	-$2K	$0	$0	$0	$0
Financing Cash Flow	$175K-23.9%	$230K+24.3%	$185K+12.1%	$165K0.0%	$165K-53.1%	$352K	$0-100.0%	$650K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

XERI Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	-293.1%	N/A
Return on Assets	N/A	-435.2%	N/A	N/A	-235.9%+34.3pp	-270.2%
Current Ratio	N/A	N/A	N/A	0.26-3.0	3.26+2.8	0.50
Debt-to-Equity	-0.00+1.1	-1.12-0.1	-1.04+0.4	-1.43-1.9	0.48+9.8	-9.29
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-287.7%	N/A	N/A	N/A	-150.9%-46.0pp	-104.9%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.000.0	-0.000.0	-0.000.0	-0.00+1.0	-1.01+0.0	-1.05+0.0	-1.06+0.1	-1.12
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$5.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Star Nav Sys Grp SNAVF

$5.5M

Dewey Electronic DEWY

$4.4M

Envir Tectonics ETCC

$18.2M

Helio Corp HLEO

$94.5M

Tel Instrument Electronics TIKK

$8.3M

Frequently Asked Questions

How much debt does Xeriant Inc have?

As of fiscal year 2025, Xeriant Inc (XERI) had $45K in cash and equivalents against $3K in long-term debt.

What are Xeriant Inc's total assets?

Xeriant Inc (XERI) had $68K in total assets as of fiscal year 2025, including both current and long-term assets.

What are Xeriant Inc's capital expenditures?

Xeriant Inc (XERI) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Xeriant Inc spend on research and development?

Xeriant Inc (XERI) invested $69K in research and development during fiscal year 2025.

How many shares does Xeriant Inc have outstanding?

Xeriant Inc (XERI) had 696M shares outstanding as of fiscal year 2025.

What is Xeriant Inc's debt-to-equity ratio?

Xeriant Inc (XERI) had a debt-to-equity ratio of -0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Xeriant Inc's debt-to-equity ratio negative or unusual?

Xeriant Inc (XERI) has negative shareholder equity of -$5.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Xeriant Inc?

Xeriant Inc (XERI) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.